These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24830647)

  • 1. Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs.
    Alanko Blomé M; Björkman P; Molnegren V; Höglund P; Widell A
    PLoS One; 2014; 9(5):e97022. PubMed ID: 24830647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam.
    Nguyen TT; Lemee V; Bollore K; Vu HV; Lacombe K; Thi XLT; Luong QA; Dubos C; Plantier JC; Thi HD; Laureillard D; Lemoine M; Tuaillon E
    BMC Infect Dis; 2018 Dec; 18(1):622. PubMed ID: 30514229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.
    Clipman SJ; Mehta SH; Mohapatra S; Srikrishnan AK; Zook KJC; Kumar MS; Lucas GM; Latkin CA; Solomon SS
    J Viral Hepat; 2024 Sep; 31(9):535-543. PubMed ID: 38837275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.
    Beld M; Penning M; van Putten M; van den Hoek A; Damen M; Klein MR; Goudsmit J
    Blood; 1999 Aug; 94(4):1183-91. PubMed ID: 10438705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.
    Cox AL; Netski DM; Mosbruger T; Sherman SG; Strathdee S; Ompad D; Vlahov D; Chien D; Shyamala V; Ray SC; Thomas DL
    Clin Infect Dis; 2005 Apr; 40(7):951-8. PubMed ID: 15824985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
    Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
    Blomé MA; Björkman P; Flamholc L; Jacobsson H; Molnegren V; Widell A
    J Viral Hepat; 2011 Dec; 18(12):831-9. PubMed ID: 21114587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
    Graham S; Maher L; Wand H; Doyle M; Iversen J
    Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.
    Keating S; Coughlan S; Connell J; Sweeney B; Keenan E
    Ir J Med Sci; 2005; 174(1):37-41. PubMed ID: 15868888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.
    Abdelwahab SF; Zakaria Z; Sobhy M; Rewisha E; Mahmoud MA; Amer MA; Del Sorbo M; Capone S; Nicosia A; Folgori A; Hashem M; El-Kamary SS
    Clin Vaccine Immunol; 2012 May; 19(5):780-6. PubMed ID: 22441392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
    Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
    J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.
    Pérez-Gracia T; Galán F; Fernández-Gutiérrez C; Girón JA; Rodríguez-Iglesias M
    Liver; 1999 Aug; 19(4):288-93. PubMed ID: 10459626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.
    Page K; Osburn W; Evans J; Hahn JA; Lum P; Asher A; Delwart E; Tobler L; Cox AL; Busch MP
    Clin Infect Dis; 2013 Feb; 56(3):405-13. PubMed ID: 23090930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.